In a highly anticipated opinion in the AseraCare case, issued on September 9, 2019, the Eleventh Circuit Court of Appeals affirmed the district court’s holding that “a clinical judgment of terminal illness warranting hospice benefits under Medicare cannot be deemed false, for the purposes of the False Claims Act, when there is only a reasonable disagreement between medical experts as to the accuracy of their conclusion, with no other evidence to prove the falsity of the assessment.” U.S. v. AseraCare, Inc., No. 16-13004, at *3 (Sept. 9, 2019 11th Cir.) (“Op.”). Although the Court remanded the case to the district court to consider any such “other evidence” the Government might identify in the record, it also made clear that such evidence would need to “link” to specific claims submitted for payment, creating a substantial practical impediment to the Government’s ability to prove falsity in this and similar cases.
Regulations, Compliance, & Enforcement
Trending Now
GSA MAS Refresh #31: Key Changes and Updates Every Contractor Should Know • CBCA Opens New Avenue for Small Enforcement Actions Under the AFCA • Cybersecurity Noncompliance as a Deal Risk: FCA Exposure in Government Contracts M&A and Private Equity • FCA Basics: Government Investigations and Self-Disclosure • Back to Basics – the Davis-Bacon Act Conformance Process
The Eleventh Circuit Remands AseraCare, But Affirms High Hurdle for Proving Falsity
Guschenkova | Shutterstock
Track False Claims Act cases, audit trends, and compliance best practices with our Compliance & Enforcement newsletter, delivering up-to-the-minute intelligence Monday–Saturday — Subscribe here.